Lifetime hormone exposure and cognition in postmenopausal women with breast cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Menopause

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/GME.0b013e3182a358c4PMID 23942248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?

  2013cited by this paper
• Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

  2012cited by this paper
• Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review.

  2012cited by this paper
• Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage

  2012cited by this paper
• Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis.

  2010cited by this paper
• Estrogen therapy and cognition: a review of the cholinergic hypothesis.

  2010cited by this paper
• Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation.

  2010cited by this paper
• Cognitive deficits as long‐term side‐effects of adjuvant therapy in breast cancer patients: ‘subjective’ complaints and ‘objective’ neuropsychological test results

  2009cited by this paper
• The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

  2005cited by this paper
• A Systematic Review of Clinical Trials of Hormone Therapy on Cognitive Function: Effects of Age at Initiation and Progestin Use

  2005cited by this paper
• Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women

  2003cited by this paper
• Estrogen and cognitive functioning in women.

  2003cited by this paper
• Estrogen exposures and memory at midlife

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• ALTERATIONS IN COGNITIVE FUNCTION DURING THE MENOPAUSAL TRANSITION

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.

  2002cited by this paper
• The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females

  2000cited by this paper
• Lifelong estrogen exposure and cognitive performance in elderly women.

  1999cited by this paper
• Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.

  1988cited by this paper

• The Feasibility and Acceptability of a Remotely Delivered, Combined Exercise Intervention on Cognitive Function in Patients With Breast Cancer Following Chemotherapy: Randomized Controlled Trial.

  2026cites this paper
• Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

  2018cites this paper